Previous Next

2024-04-04

Bone mineral density and breast cancer

Oncology

In this study, researchers evaluated the long-term impact (over a total period of 10 years) of breast cancer and its treatment on bone mineral density, particularly after discontinuation of treatment with an aromatase inhibitor. A total of 372 patients with pre- and post-menopausal breast cancer were included in the study. Discontinuation of the aromatase inhibitor at 5 years had a significant impact on bone mineral density. Bone mineral density increased in patients weaned off the aromatase inhibitor during the first 5 years, while a decrease in bone mineral density was observed in patients without aromatase inhibitor weaning.

Source(s) :
Carl Blomqvist et al. Long-term effects of aromatase inhibitor withdrawal on bone mineral density in early breast cancer patients: 10-year follow-up results of the BREX study. Breast Cancer Res Treat. 2024 Apr 1 ;

Last press reviews


Dengue: Is safe vaccination possible?

#Dengue #Vaccine #Immunity #ADE #Virus #Immunogenicity <br>

One vaccine, two viruses, a thousand hopes

#COVID19 #SARSCoV2 #vaccine<br><br><br>COVID-19,...

West Nile: the fever is rising!

#WestNile #Mosquito #Epidemiology #Zoonosis<br><br><br>West Nile...